Innovator Drug Sales Dashboard
In 2023, global sales reached approximately $1.6 trillion. Our platform highlights over 500 innovator drugs, contributing to a market value of nearly $650 billion.
The leading therapy areas for innovative drugs were oncology, immunology and endocrinology, which together made up 56% of worldwide sales in 2023. Endocrinology saw a YoY growth of 7.2%, whereas oncology showed a YoY growth of 0.4%. By contrast, immunology showed a negative YoY growth of 6.8%. Sales of anti-viral drugs have dropped a significant 45% since 2022.
For a deeper understanding, you can explore extensive six-year sales data from leading global pharmaceutical companies, meticulously organized by therapy areas.
Research & Advisory Services for Pharmaceutical Companies
We guide clients throughout their product's lifecycle - from research to commercialization. We offer expertise in pharmaceuticals across various therapeutic areas and regions. Our services include Disease Landscape Assessment, Competitive Intelligence, Patient Journey Evaluation, Stakeholder Insights, Pricing and Market Access, Commercial Opportunity Assessment, Brand Strategy, Real World Evidence Studies, and M&A Due Diligence.
Therapy Insights
Uncovering insights into therapy area advancements, patient journeys, and cutting-edge treatments, empowering informed decision-making in an ever-evolving healthcare landscape.
- Immunology
- Neurology
- Cardiometabolic
- Oncology
- Drug Development
- Respiratory
- Infectious Disease
- Cell and Gene Therapy
- Others
Perspectives
Client Stories
Client Testimonials
Talk To Us
We will connect you to the right professional within our Healthcare Research & Advisory Team